Q2 FY26 results: consolidated PAT up 6%, revenue growth modest
ALEMBICLTD · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts more than Nifty Microcap 250 and 3.3 pts more than its Residential Commercial Projects peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Alembic posted Q2 FY26 consolidated revenue of Rs 5,586 lakhs (up 5.6 percent YoY) and net profit including associate share at Rs 12,849 lakhs (up 6.2 percent YoY). H1 FY26 consolidated PAT was Rs 19,013 lakhs. Other Income of Rs 6,492 lakhs in Q2 is mainly dividend from associate Alembic Pharmaceuticals. Standalone net profit was flat at Rs 7,563 lakhs. Auditors flagged an emphasis of matter on a disputed electricity duty case, Rs 2,052 lakhs provided and Rs 35 crore deposited with the Supreme Court.
Operating earnings largely flat; profits lifted by associate dividends. Watch electricity duty case outcome for any extra liability.